| Literature DB >> 31599013 |
Norito Katoh1, Yukihiro Ohya2, Masanori Ikeda3, Tamotsu Ebihara4, Ichiro Katayama5, Hidehisa Saeki6, Naoki Shimojo7, Akio Tanaka8, Takeshi Nakahara9, Mizuho Nagao10, Michihiro Hide8, Yuji Fujita7, Takao Fujisawa11, Masaki Futamura12, Koji Masuda1, Hiroyuki Murota13, Kiwako Yamamoto-Hanada2.
Abstract
Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.Entities:
Keywords: atopic dermatitis; clinical practice guidelines; clinical questions; evidence-based medicine; treatment
Mesh：
Substances：
Year: 2019 PMID： 31599013 DOI： 10.1111/1346-8138.15090
Source DB: PubMed Journal: J Dermatol ISSN： 0385-2407 Impact factor: 4.005